Search

Your search keyword '"Proteases -- Planning"' showing total 2 results
Start Over Descriptor "Proteases -- Planning" Journal fair disclosure wire
2 results on '"Proteases -- Planning"'

1. Q1 2011 Roche Holding AG Sales Conference Call - Final

Subjects
Protease inhibitors -- Planning, Medical research, Rheumatoid factor, Proteases -- Planning, Papillomavirus infections -- Care and treatment, Lung cancer -- Care and treatment, Blood sugar, Medical care, Cost of, Medicine, Experimental, Medicare -- Planning, Metastasis -- Care and treatment, Sugars, Stomach cancer -- Care and treatment, Angiogenesis inhibitors, Chief financial officers -- Planning, Boats and boating, Ovarian cancer -- Care and treatment, Rheumatoid arthritis -- Care and treatment, Company securities, Company business planning, Business
Abstract

Presentation SEVERIN SCHWAN, CEO, ROCHE HOLDING AG: Good afternoon, ladies and gentlemen. Welcome to our conference call. This is Severin Schwan speaking. With me in the room is Pascal Soriot, [...]

Published
2011

2. Event Brief of Vertex Pharmaceuticals Incorporated Strengthens HCV Drug Development Portfolio, Adds Novel Polymerase Inhibitors to Shape New Combinations with Telaprevir Conference Call - Final

Subjects
Vertex Pharmaceuticals Inc. -- Planning, Interferon -- Planning, Protease inhibitors -- Dosage and administration -- Planning, Medical research, Medicine, Experimental, Financial analysts -- Planning, Proteases -- Planning, Financial markets, Drug therapy, Combination, Biological response modifiers, Securities offerings, Hepatitis C -- Care and treatment, Pharmaceutical industry -- Planning, Company business planning, Business
Abstract

PARTICIPANTS . Michael Partridge, Vertex Pharmaceuticals, Inc., Senior Director of Strategic Communications . Kurt Graves, Vertex Pharmaceuticals, Inc., EVP, Chief Commercial Officer, Head of Development . Freda Lewis-Hall, Vertex Pharmaceuticals, [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results